Back to search

Cornell University

TUMOR-SPECIFIC DRAINING LYMPH NODE CD8 T CELLS ORCHESTRATE AN ANTI-TUMOR RESPONSE TO PD-1 IMMUNE CHECKPOINT BLOCKADE

Abstract

dc:description.abstract

PD-1 immune checkpoint blockade (ICB) with platinum chemotherapy (ChemoIO) has transformed treatment for resectable non-small cell lung cancer (NSCLC). PD-1 ICB was established to reinvigorate tumor T cells and reduce T cell exhaustion. However, the impact of PD-1 blockade on the induction and maintenance of tumor-relevant tdLN T cells and functional T cell memory in the context of surgical resection is not fully understood. We hypothesize that T cells activated in the tumor-draining lymph node (tdLN) also respond to PD-I ICB. Clonal dynamics were assessed across tissues using single-cell TCR barcoding integrated with transcriptional profiling (scRNA sequencing) by using machine learning (ML) and bioinformatic approaches. Using this approach, we determined the contribution of tumor-specific tdLN T cell clones. In chapter 2, we demonstrate that tdLN-paired clones are less exhausted than clones that are only found in the tumor. We establish that there are two distinct populations of LN-paired clones: those that directly link from the tdLN and tumor (tdLN-tumor paired) with tumor killing capacity, and clones that circulate within the blood with cytotoxic memory surveillance potential. Furthermore, the distinction of these two LN-paired subsets is found in the earliest memory state of expanded tumor-specific tdLN T cells and is reflected in the tumor as similarly more differentiated, effector subsets. ChemoIO was also found to directly impact tdLN-paired clonal diversity and phenotypic differentiation. In chapter 3, we demonstrate that we can further enhance and alter tumor-specific tdLN T cells with the addition of IL15-Ra in a non-small cell lung cancer mouse model. This combination therapy of IL15-Ra and PD-1 ICB increased a cytotoxic KILR effector function within memory-like tdLN T cells and in the effector tumor T cells. Combination therapy of IL15-Ra and PD-1 ICB also increased the proportion of persisting LN-paired clones 30 days after resection. Initial clonal averages KILR function within the tdLN and tumor at the time of resection were increased in clones that persisted versus those that did not. Together, our results indicate that the tdLN not only contributes to anti-tumor response but also has its own response to ICB therapy in addition to the tumor.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Biomedical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Cornell University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Honigsberg, Rachel
Chair dc:contributor.chair
  • Elemento, Olivier
Committee members dc:contributor.committeemember
  • Guzman, Monica
  • Mezey, Jason

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
16938455
Dc Identifier Other
ProQuest Submission ID: 14900
ProQuest Publication ID: 31997517

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Honigsberg, Rachel. TUMOR-SPECIFIC DRAINING LYMPH NODE CD8 T CELLS ORCHESTRATE AN ANTI-TUMOR RESPONSE TO PD-1 IMMUNE CHECKPOINT BLOCKADE. Doctor of Philosophy thesis, Cornell University, 2025. https://hdl.handle.net/1813/117572